| ADIPOQ/adiponectin induces cytotoxic autophagy in breast cancer cells through STK11/LKB1-mediated activation of the AMPK-ULK1 axis SJ Chung, GP Nagaraju, A Nagalingam, N Muniraj, P Kuppusamy, ... Autophagy 13 (8), 1386-1403, 2017 | 170 | 2017 |
| A procarcinogenic colon microbe promotes breast tumorigenesis and metastatic progression and concomitantly activates notch and β-catenin axes S Parida, S Wu, S Siddharth, G Wang, N Muniraj, A Nagalingam, C Hum, ... Cancer discovery 11 (5), 1138-1157, 2021 | 106 | 2021 |
| Activation of tumor suppressor LKB1 by honokiol abrogates cancer stem-like phenotype in breast cancer via inhibition of oncogenic Stat3 S Sengupta, A Nagalingam, N Muniraj, MY Bonner, P Mistriotis, A Afthinos, ... Oncogene 36 (41), 5709-5721, 2017 | 92 | 2017 |
| Trefoil factor-1 (TFF1) enhances oncogenicity of mammary carcinoma cells N Amiry, X Kong, N Muniraj, N Kannan, PM Grandison, J Lin, Y Yang, ... Endocrinology 150 (10), 4473-4483, 2009 | 91 | 2009 |
| Regulation of chemokines and cytokines by histone deacetylases and an update on histone decetylase inhibitors in human diseases HR Gatla, N Muniraj, P Thevkar, S Yavvari, S Sukhavasi, MR Makena International journal of molecular sciences 20 (5), 1110, 2019 | 84 | 2019 |
| STAT3α is oncogenic for endometrial carcinoma cells and mediates the oncogenic effects of autocrine human growth hormone JZ Tang, XJ Kong, A Banerjee, N Muniraj, V Pandey, M Steiner, JK Perry, ... Endocrinology 151 (9), 4133-4145, 2010 | 50 | 2010 |
| Hydrogen sulfide acts as a pro‐inflammatory mediator in rheumatic disease N Muniraj, LK Stamp, A Badiei, A Hegde, V Cameron, M Bhatia International journal of rheumatic diseases 20 (2), 182-189, 2017 | 45 | 2017 |
| Benzyl Isothiocyanate potentiates p53 signaling and antitumor effects against breast cancer through activation of p53-LKB1 and p73-LKB1 axes B Xie, A Nagalingam, P Kuppusamy, N Muniraj, P Langford, B Győrffy, ... Scientific reports 7 (1), 40070, 2017 | 40 | 2017 |
| Withaferin A inhibits lysosomal activity to block autophagic flux and induces apoptosis via energetic impairment in breast cancer cells N Muniraj, S Siddharth, A Nagalingam, A Walker, J Woo, B Győrffy, ... Carcinogenesis 40 (9), 1110-1120, 2019 | 39 | 2019 |
| Bioactive compounds: Multi-targeting silver bullets for preventing and treating breast cancer N Muniraj, S Siddharth, D Sharma Cancers 11 (10), 1563, 2019 | 32 | 2019 |
| Inhibition of hydrogen sulfide production by gene silencing attenuates inflammatory activity by downregulation of NF-κB and MAP kinase activity in LPS-activated RAW 264.7 cells A Badiei, N Muniraj, S Chambers, M Bhatia BioMed research international 2014, 2014 | 32 | 2014 |
| Concomitant inhibition of cytoprotective autophagy augments the efficacy of withaferin A in hepatocellular carcinoma S Siddharth, N Muniraj, NK Saxena, D Sharma Cancers 11 (4), 453, 2019 | 24 | 2019 |
| Concomitant activation of ETS-like transcription factor-1 and Death Receptor-5 via extracellular signal-regulated kinase in withaferin A-mediated inhibition of … P Kuppusamy, A Nagalingam, N Muniraj, NK Saxena, D Sharma Scientific reports 7 (1), 17943, 2017 | 24 | 2017 |
| Induction of STK11-dependent cytoprotective autophagy in breast cancer cells upon honokiol treatment N Muniraj, S Siddharth, M Shriver, A Nagalingam, S Parida, J Woo, ... Cell death discovery 6 (1), 81, 2020 | 17 | 2020 |
| A procarcinogenic colon microbe promotes breast tumorigenesis and metastatic progression and concomitantly activates notch and β-catenin axes. Cancer Discov. 2021; 11: 1138 … S Parida, S Wu, S Siddharth, G Wang, N Muniraj, A Nagalingam, C Hum, ... DOI: https://doi. org/10.1158/2159-8290. CD-20-0537. PMID: https://www. ncbi …, 0 | 17 | |
| Hyperleptinemia in obese state renders luminal breast cancers refractory to tamoxifen by coordinating a crosstalk between Med1, miR205 and ErbB A Nagalingam, S Siddharth, S Parida, N Muniraj, D Avtanski, ... NPJ Breast Cancer 7 (1), 105, 2021 | 13 | 2021 |
| Role of gut microbiota in breast cancer and drug resistance S Viswanathan, S Parida, BT Lingipilli, R Krishnan, DR Podipireddy, ... Pathogens 12 (3), 468, 2023 | 11 | 2023 |
| Novel molecules as the emerging trends in cancer treatment: an update P Sekar, R Ravitchandirane, S Khanam, N Muniraj, AV Cassinadane Medical Oncology 39 (2), 20, 2022 | 11 | 2022 |
| Hydrogen sulphide: a new tool to design and develop drugs N Muniraj Clinical Anti-Inflammatory & Anti-Allergy Drugs 1 (1), 57-66, 2014 | 7 | 2014 |
| Concomitant activation of GLI1 and Notch1 contributes to racial disparity of human triple negative breast cancer progression S Siddharth, S Parida, N Muniraj, S Hercules, D Lim, A Nagalingam, ... Elife 10, e70729, 2021 | 6 | 2021 |
Sumit SiddharthPostdoctoral Fellow, Dept of Oncology, School of Medicine, Johns Hopkins University and SidneyVerified email at jhmi.edu
